Penicillin has nearly eradicated rheumatic heart disease (RHD) in the United States. But 15 million people still suffer with the disease worldwide, and 1.4 million die each year, according to World Heart Federation.
Access to penicillin can prevent deaths from RHD. Researchers from Case Western Reserve University, Makerere University and the Uganda Heart Institute at Mulago Hospital, a national referral hospital in Kampala, collaborated to learn about those obstacles to receive the medication and find ways to overcome them.
The researchers heard from some Ugandans that paying for an injection meant that other family members might go without food. Others didn't want to pay because they believed the person with heart disease would die anyway.
Their findings were reported in the Global Heart article, "A Qualitative Examination of Secondary Prophylaxis in Rheumatic Heart Disease."
RHD, which develops as an inappropriate immune system response to strep infection, is the most common cause of heart disease for Ugandans between age 15 and 49. The body develops an autoimmune reaction that causes an inflammation and destruction of the heart valves. Penicillin controls the inflammation by preventing strep infection.
Reaching people with information about the penicillin injections hasn't been easy, said Allison Webel, assistant professor of nursing at Case Western Reserve's Frances Payne Bolton School of Nursing and one of the researchers.
Webel collaborated with Case Western Reserve researchers Daniel Huck (School of Medicine), Scott Frank (Department of Epidemiology and Biostatistics and Family Medicine, School of Medicine), and Chris Longenecker (Division of Cardiology, School of Medicine) and Ugandan collaborators Haddy Nalubwama (School of Public Health, Makerere University) and Emmy Okello (Uganda Heart Institute, Mulago Hospital).
The researchers organized five focus groups, with six to eight participants each, and asked questions about their experiences in accessing and receiving monthly penicillin injections.
The biggest reasons people gave for not getting injections were money and transportation, followed by pain, fear of the injection and poor knowledge about the consequences of a missed treatment.
While many families were supportive, the individuals felt a stigma for having the health condition and being a burden to their families. Webel said some people with RHD were uncomfortable having penicillin injections that might be mistaken for treatments for syphilis by the health-care workers. Also, system-wide barriers prevented easy access to treatments: lack of clinics in their local communities, unskilled health-care workers giving injections that were painful, a shortage of penicillin and long waits at the clinics.
The researchers found that while there were significant barriers, there were also important factors that helped them get injections. For example, patients reported that their symptoms worsened when they missed their monthly injections, which helped keep them motivated to go. Injection reminders and personal motivation also kept them on schedule.
Explore further: Handheld echocardiography ups rheumatic heart disease detection
Medical Xpress on facebook
Related Stories
How can supply of penicillin be an issue in any country in 2013?
Benzathine penicillin G (BPG) is the most essential antibiotic for the treatment and prevention of group A streptococcal infections associated with rheumatic fever and rheumatic heart disease. Yet while some countries such ...
Echocardiography detecting many more cases of definite and borderline rheumatic heart disease
How using echocardiography is increasing detection rates of rheumatic heart disease (RHD) many-fold is the subject of one of the papers in the RHD special issue of Global Heart, the journal of the World Heart Federation, and wr ...
Handheld echocardiography ups rheumatic heart disease detection
(HealthDay)—Handheld echocardiography (HAND) and auscultation improves detection of rheumatic heart disease (RHD) compared with auscultation alone, according to a study published online March 16 in Pediatrics.
'Utter neglect' of rheumatic heart disease revealed by results from global study
Rheumatic heart disease (RHD) - the most common acquired heart disease in children in many countries of the world - is being neglected and poorly treated, according to new findings from the Global Rheumatic Heart Disease ...
Rheumatic heart disease treatment is too late to prevent heart surgery in the Middle East
Patients with rheumatic heart disease (RHD) are being admitted to hospital too late to prevent the need for heart surgery, according to a new study carried out by doctors in Yemen and presented today at the World Congress ...
Recommended for you
Patients with doctors who review meds with them are healthier
Physicians who routinely review with their patients the medications they should be taking are more likely to have patients adhere to their medications and achieve health goals, according to a University of ...
Study links genetic variation in a receptor on the platelet to an increase in the risk for thrombosis
Coronary heart disease and stroke, two of the leading causes of death in the United States, are diseases associated with heightened platelet reactivity. A new study in humans suggests an underlying reason for the variability ...
New recommendations for treating patients with high blood pressure and CVD
A new scientific statement issued jointly by three medical organizations and published in the American Heart Association's journal Hypertension, addresses how low to aim when treating patients with high b ...
New stroke prevention efforts may be paying off
(HealthDay)—Fewer people are being treated in U.S. emergency rooms for strokes caused by blood clots in the brain, which experts read as a sign that current stroke prevention methods are working.
FDA expands approval for 'valve in valve' aortic replacement
(HealthDay)—The U.S. Food and Drug Administration said Tuesday that use of the CoreValve "valve-in-valve" aortic replacement has been expanded to include people at extreme risk for serious complications of traditional ...
New resuscitation guidelines for severely hypothermic patients in cardiac arrest
The general rule for treatment of patients in cardiac arrest is that once resuscitation measures have begun, they must be continued uninterruptedly until the patient shows signs of life or is pronounced dead. A new study ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
Penicillin has nearly eradicated rheumatic heart disease (RHD) in the United States. But 15 million people still suffer with the disease worldwide, and 1.4 million die each year, according to World Heart Federation.
Access to penicillin can prevent deaths from RHD. Researchers from Case Western Reserve University, Makerere University and the Uganda Heart Institute at Mulago Hospital, a national referral hospital in Kampala, collaborated to learn about those obstacles to receive the medication and find ways to overcome them.
The researchers heard from some Ugandans that paying for an injection meant that other family members might go without food. Others didn't want to pay because they believed the person with heart disease would die anyway.
Their findings were reported in the Global Heart article, "A Qualitative Examination of Secondary Prophylaxis in Rheumatic Heart Disease."
RHD, which develops as an inappropriate immune system response to strep infection, is the most common cause of heart disease for Ugandans between age 15 and 49. The body develops an autoimmune reaction that causes an inflammation and destruction of the heart valves. Penicillin controls the inflammation by preventing strep infection.
Reaching people with information about the penicillin injections hasn't been easy, said Allison Webel, assistant professor of nursing at Case Western Reserve's Frances Payne Bolton School of Nursing and one of the researchers.
Webel collaborated with Case Western Reserve researchers Daniel Huck (School of Medicine), Scott Frank (Department of Epidemiology and Biostatistics and Family Medicine, School of Medicine), and Chris Longenecker (Division of Cardiology, School of Medicine) and Ugandan collaborators Haddy Nalubwama (School of Public Health, Makerere University) and Emmy Okello (Uganda Heart Institute, Mulago Hospital).
The researchers organized five focus groups, with six to eight participants each, and asked questions about their experiences in accessing and receiving monthly penicillin injections.
The biggest reasons people gave for not getting injections were money and transportation, followed by pain, fear of the injection and poor knowledge about the consequences of a missed treatment.
While many families were supportive, the individuals felt a stigma for having the health condition and being a burden to their families. Webel said some people with RHD were uncomfortable having penicillin injections that might be mistaken for treatments for syphilis by the health-care workers. Also, system-wide barriers prevented easy access to treatments: lack of clinics in their local communities, unskilled health-care workers giving injections that were painful, a shortage of penicillin and long waits at the clinics.
The researchers found that while there were significant barriers, there were also important factors that helped them get injections. For example, patients reported that their symptoms worsened when they missed their monthly injections, which helped keep them motivated to go. Injection reminders and personal motivation also kept them on schedule.
Explore further: Handheld echocardiography ups rheumatic heart disease detection
Medical Xpress on facebook
Related Stories
How can supply of penicillin be an issue in any country in 2013?
Benzathine penicillin G (BPG) is the most essential antibiotic for the treatment and prevention of group A streptococcal infections associated with rheumatic fever and rheumatic heart disease. Yet while some countries such ...
Echocardiography detecting many more cases of definite and borderline rheumatic heart disease
How using echocardiography is increasing detection rates of rheumatic heart disease (RHD) many-fold is the subject of one of the papers in the RHD special issue of Global Heart, the journal of the World Heart Federation, and wr ...
Handheld echocardiography ups rheumatic heart disease detection
(HealthDay)—Handheld echocardiography (HAND) and auscultation improves detection of rheumatic heart disease (RHD) compared with auscultation alone, according to a study published online March 16 in Pediatrics.
'Utter neglect' of rheumatic heart disease revealed by results from global study
Rheumatic heart disease (RHD) - the most common acquired heart disease in children in many countries of the world - is being neglected and poorly treated, according to new findings from the Global Rheumatic Heart Disease ...
Rheumatic heart disease treatment is too late to prevent heart surgery in the Middle East
Patients with rheumatic heart disease (RHD) are being admitted to hospital too late to prevent the need for heart surgery, according to a new study carried out by doctors in Yemen and presented today at the World Congress ...
Recommended for you
Patients with doctors who review meds with them are healthier
Physicians who routinely review with their patients the medications they should be taking are more likely to have patients adhere to their medications and achieve health goals, according to a University of ...
Study links genetic variation in a receptor on the platelet to an increase in the risk for thrombosis
Coronary heart disease and stroke, two of the leading causes of death in the United States, are diseases associated with heightened platelet reactivity. A new study in humans suggests an underlying reason for the variability ...
New recommendations for treating patients with high blood pressure and CVD
A new scientific statement issued jointly by three medical organizations and published in the American Heart Association's journal Hypertension, addresses how low to aim when treating patients with high b ...
New stroke prevention efforts may be paying off
(HealthDay)—Fewer people are being treated in U.S. emergency rooms for strokes caused by blood clots in the brain, which experts read as a sign that current stroke prevention methods are working.
FDA expands approval for 'valve in valve' aortic replacement
(HealthDay)—The U.S. Food and Drug Administration said Tuesday that use of the CoreValve "valve-in-valve" aortic replacement has been expanded to include people at extreme risk for serious complications of traditional ...
New resuscitation guidelines for severely hypothermic patients in cardiac arrest
The general rule for treatment of patients in cardiac arrest is that once resuscitation measures have begun, they must be continued uninterruptedly until the patient shows signs of life or is pronounced dead. A new study ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
0 comments:
Post a Comment